Medical Intelligence Quiz
Challenge Yourself, Build Your Knowledge
Bladder cancer presentation
Question 1 of 4
Topics
Fast Facts Friday
Fast Facts Friday
| Quiz | |
|---|---|
| Fast Facts Friday, July 14, 2023 | Take Quiz |
| Fast Facts Friday, July 7, 2023 | Take Quiz |
| Fast Facts Friday, June 30, 2023 | Take Quiz |
| Fast Facts Friday, June 23, 2023 | Take Quiz |
| Fast Facts Friday, June 16, 2023 | Take Quiz |
| Fast Facts Friday, June 9, 2023 | Take Quiz |
| Fast Facts Friday, June 2, 2023 | Take Quiz |
| Fast Facts Friday, May 26, 2023 | Take Quiz |
| Fast Facts Friday, May 19, 2023 | Take Quiz |
| Fast Facts Friday, May 12, 2023 | Take Quiz |
| Fast Facts Friday, May 5, 2023 | Take Quiz |
| Fast Facts Friday, April 28, 2023 | Take Quiz |
| Fast Facts Friday, April 21, 2023 | Take Quiz |
| Fast Facts Friday, April 14, 2023 | Take Quiz |
| Fast Facts Friday, April 7, 2023 | Take Quiz |
| Fast Facts Friday, March 31, 2023 | Take Quiz |
| Fast Facts Friday, March 24, 2023 | Take Quiz |
| Fast Facts Friday, March 17, 2023 | Take Quiz |
| Fast Facts Friday, March 10, 2023 | Take Quiz |
| Fast Facts Friday, March 3, 2023 | Take Quiz |
| Fast Facts Friday, February 24, 2023 | Take Quiz |
| Fast Facts Friday, February 17, 2023 | Take Quiz |
| Fast Facts Friday, February 10, 2023 | Take Quiz |
| Fast Facts Friday, February 3, 2023 | Take Quiz |
| Fast Facts Friday, January 27, 2023 | Take Quiz |
| Fast Facts Friday, January 20, 2023 | Take Quiz |
| Fast Facts Friday, January 13, 2023 | Take Quiz |
| Fast Facts Friday, January 6, 2023 | Take Quiz |
| Fast Facts Friday, December 30, 2022 | Take Quiz |
| Fast Facts Friday, December 23, 2022 | Take Quiz |
| Fast Facts Friday, December 16, 2022 | Take Quiz |
| Fast Facts Friday, December 9, 2022 | Take Quiz |
| Fast Facts Friday, December 2, 2022 | Take Quiz |
| Fast Facts Friday, November 25, 2022 | Take Quiz |
| Fast Facts Friday, November 18, 2022 | Take Quiz |
| Fast Facts Friday, November 11, 2022 | Take Quiz |
| Fast Facts Friday, November 4, 2022 | Take Quiz |
| Fast Facts Friday, October 28, 2022 | Take Quiz |
| Fast Facts Friday, October 21, 2022 | Take Quiz |
| Fast Facts Friday, October 14, 2022 | Take Quiz |
| Fast Facts Friday, October 7, 2022 | Take Quiz |
| Fast Facts Friday, September 30, 2022 | Take Quiz |
| Fast Facts Friday, September 23, 2022 | Take Quiz |
| Fast Facts Friday, September 16, 2022 | Take Quiz |
| Fast Facts Friday, September 9, 2022 | Take Quiz |
| Fast Facts Friday, September 2, 2022 | Take Quiz |
| Fast Facts Friday, August 26, 2022 | Take Quiz |
| Fast Facts Friday, August 19, 2022 | Take Quiz |
| Fast Facts Friday August 12, 2022 | Take Quiz |
| Fast Facts Friday, August 5, 2022 | Take Quiz |
| Fast Facts Friday, July 29, 2022 | Take Quiz |
| Fast Facts Friday, July 22, 2022 | Take Quiz |
| Fast Facts Friday, July 15, 2022 | Take Quiz |
| Fast Facts Friday, July 8, 2022 | Take Quiz |
| Fast Facts Friday, July 1, 2022 | Take Quiz |
| Fast Facts Friday, June 24, 2022 | Take Quiz |
| Fast Facts Friday, June 17, 2022 | Take Quiz |
| Fast Facts Friday, June 10, 2022 | Take Quiz |
| Fast Facts Friday, June 3, 2022 | Take Quiz |
| Fast Facts Friday, May 27, 2022 | Take Quiz |
| Fast Facts Friday, May 20, 2022 | Take Quiz |
| Fast Facts Friday, May 13, 2022 | Take Quiz |
| Fast Facts Friday, May 6, 2022 | Take Quiz |
| Fast Facts Friday, April 29, 2022 | Take Quiz |
| Fast Facts Friday, April 22, 2022 | Take Quiz |
| Fast Facts Friday, April 15, 2022 | Take Quiz |
| Fast Facts Friday, April 8, 2022 | Take Quiz |
| Fast Facts Friday, April 1, 2022 | Take Quiz |
| Fast Facts Friday, March 25, 2022 | Take Quiz |
| Fast Facts Friday, March 18, 2022 | Take Quiz |
| Fast Facts Friday, March 11th, 2022 | Take Quiz |
| Fast Facts Friday, March 4, 2022 | Take Quiz |
| Fast Facts Friday, February 25, 2022 | Take Quiz |
| Fast Facts Friday, February 18, 2022 | Take Quiz |
| Fast Facts Friday, February 11th, 2022 | Take Quiz |
| Fast Facts Friday, February 4th, 2022 | Take Quiz |
| Fast Facts Friday, January 28th, 2022 | Take Quiz |
| Fast Facts Friday, January 21, 2022 | Take Quiz |
| Fast Facts Friday, January 14th, 2022 | Take Quiz |
| Fast Facts Friday, January 7th, 2022 | Take Quiz |
| Fast Facts Friday, December 31st, 2021 | Take Quiz |
| Fast Facts Friday, December 24th, 2021 | Take Quiz |
| Fast Facts Friday, December 17th, 2021 | Take Quiz |
| Fast Facts Friday, December 10th, 2021 | Take Quiz |
| Fast Facts Friday, December 3rd, 2021 | Take Quiz |
| Fast Facts Friday, November 26th, 2021 | Take Quiz |
| Fast Facts Friday, November 19th, 2021 | Take Quiz |
| Fast Facts Friday, November 12th, 2021 | Take Quiz |
| Fast Facts Friday, November 5th, 2021 | Take Quiz |
| Fast Facts Friday, October 29th, 2021 | Take Quiz |
| Fast Facts Friday, October 22nd, 2021 | Take Quiz |
| Fast Facts Friday, October 15th, 2021 | Take Quiz |
| Fast Facts Friday, October 8th, 2021 | Take Quiz |
| Fast Facts Friday, October 1st, 2021 | Take Quiz |
| Fast Facts Friday, September 24th, 2021 | Take Quiz |
| Fast Facts Friday, September 17th, 2021 | Take Quiz |
| Fast Facts Friday: September 10th, 2021 | Take Quiz |
| Fast Facts Friday, September 3rd, 2021 | Take Quiz |
| Fast Facts Friday, Aug 27th, 2021 | Take Quiz |
| Fast Facts Friday, Aug 20th, 2021 | Take Quiz |
| Fast Facts Friday: June 18, 2021 | Take Quiz |
| Fast Facts Friday: April 16, 2021 | Take Quiz |
| Fast Facts Friday: April 9, 2021 | Take Quiz |
| Fast Facts Friday: April 2, 2021 | Take Quiz |
| Fast Facts Friday: March 26, 2021 | Take Quiz |
| Fast Facts Friday: March 19, 2021 | Take Quiz |
| Fast Facts Friday: March 12, 2021 | Take Quiz |
| Fast Facts Friday: March 5, 2021 | Take Quiz |
| Fast Facts Friday: February 26, 2021 | Take Quiz |
| Fast Facts Friday: February 19, 2021 | Take Quiz |
| Fast Facts Friday: February 12, 2020 | Take Quiz |
| Fast Facts Friday: February 5, 2021 | Take Quiz |
| Fast Facts Friday: January 29, 2021 | Take Quiz |
| Fast Facts Friday: January 22, 2021 | Take Quiz |
| Fast Facts Friday: January 15, 2021 | Take Quiz |
| Fast Facts Friday: January 8, 2021 | Take Quiz |
| Fast Facts Friday: December 18, 2020 | Take Quiz |
| Fast Facts Friday: December 11, 2020 | Take Quiz |
| Fast Facts Friday: December 4th, 2020 | Take Quiz |
| Fast Facts Friday: November 20, 2020 | Take Quiz |
| Fast Facts Friday: November 13, 2020 | Take Quiz |
| Fast Facts Friday: November 6, 2020 | Take Quiz |
| Fast Facts Friday: October 30, 2020 | Take Quiz |
| Fast Facts Friday: October 23, 2020 | Take Quiz |
| Fast Facts Friday: October 16, 2020 | Take Quiz |
| Fast Facts Friday: October 9, 2020 | Take Quiz |
| Fast Facts Friday: October 2, 2020 | Take Quiz |
| Fast Facts Friday: September 25, 2020 | Take Quiz |
| Fast Facts Friday: September 18, 2020 | Take Quiz |
| Fast Facts Friday: September 11, 2020 | Take Quiz |
| Fast Facts Friday: September 4, 2020 | Take Quiz |
| Fast Facts Friday: August 28, 2020 | Take Quiz |
| Fast Facts Friday: August 21, 2020 | Take Quiz |
| Fast Facts Friday: August 14, 2020 | Take Quiz |
| Fast Facts Friday: August 7, 2020 | Take Quiz |
| Fast Facts Friday: July 31, 2020 | Take Quiz |
| Fast Facts Friday: July 24, 2020 | Take Quiz |
| Fast Facts Friday: July 17, 2020 | Take Quiz |
| Fast Facts Friday: July 10, 2020 | Take Quiz |
| Fast Facts Friday: July 3, 2020 | Take Quiz |
| Fast Facts Friday: June 26, 2020 | Take Quiz |
| Fast Facts Friday: June 19, 2020 | Take Quiz |
| Fast Facts Friday: June 12, 2020 | Take Quiz |
| Fast Facts Friday: June 5, 2020 | Take Quiz |
| Fast Facts Friday: May 29th, 2020 | Take Quiz |
| Fast Facts Friday: May 22, 2020 | Take Quiz |
| Fast Facts Friday: May 15, 2020 | Take Quiz |
| Fast Facts Friday: May 8, 2020 | Take Quiz |
| Fast Facts Friday: March 13, 2020 | Take Quiz |
| Fast Facts Friday: March 6, 2020 | Take Quiz |
| Fast Facts Friday: February 28, 2020 | Take Quiz |
| Fast Facts Friday: October 4, 2019 | Take Quiz |
| Fast Facts Friday: September 27, 2019 | Take Quiz |
| Fast Facts Friday: August 30, 2019 | Take Quiz |
| Fast Facts Friday: May 24, 2019 | Take Quiz |
| Fast Facts Friday: May 17, 2019 | Take Quiz |
| Fast Facts Friday: May 10, 2019 | Take Quiz |
| Fast Facts Friday: May 3, 2019 | Take Quiz |
| Fast Facts Friday: April 26, 2019 | Take Quiz |
| Fast Facts Friday: April 19, 2019 | Take Quiz |
| Fast Facts Friday: April 12, 2019 | Take Quiz |
| Fast Facts Friday: April 5, 2019 | Take Quiz |
| Fast Facts Friday: March 29, 2019 | Take Quiz |
| Fast Facts Friday: March 22, 2019 | Take Quiz |
| Fast Facts Friday: March 15, 2019 | Take Quiz |
| Fast Facts Friday: March 8, 2019 | Take Quiz |
| Fast Facts Friday: March 1, 2019 | Take Quiz |
| Fast Facts Friday: February 22, 2019 | Take Quiz |
| Fast Facts Friday: February 15, 2019 | Take Quiz |
| Fast Facts Friday: February 8, 2019 | Take Quiz |
| Fast Facts Friday: February 1, 2019 | Take Quiz |
Ovarian Cancer
Ovarian Cancer
| Quiz | |
|---|---|
| Ovarian Cancer Presentation and Diagnosis | Take Quiz |
| Ovarian Cancer and Obesity | Take Quiz |
| Ovarian Cancer Subtypes | Take Quiz |
| Ovarian Cancer Surgical Complications | Take Quiz |
| Ovarian Cancer Risk Factors | Take Quiz |
| Ovarian Cancer Guidelines | Take Quiz |
Breast Cancer
Breast Cancer
| Quiz | |
|---|---|
| Breast Cancer Diagnosis | Take Quiz |
| Breast Cancer Exercise Interventions | Take Quiz |
| Venous Access Ports in Breast Cancer | Take Quiz |
| Male Breast Cancer | Take Quiz |
| Breast Cancer Risk Factors | Take Quiz |
| SABCS 2021: Efficacy of selective estrogen receptor degrader in estrogen receptor–positive breast cancer | Take Quiz |
| Breast cancer and gut microbiota | Take Quiz |
| Breast cancer and gut microbiota | Take Quiz |
| Lobular and ductal breast carcinoma | Take Quiz |
| Breast cancer subtype treatment and outcomes | Take Quiz |
| Breast cancer diagnosis | Take Quiz |
| Breast cancer types | Take Quiz |
| Breast cancer screening | Take Quiz |
| Neoadjuvant therapy in breast cancer | Take Quiz |
| Genetic risk for breast cancer by race in the U.S. | Take Quiz |
| Advanced breast cancer among women in the United States | Take Quiz |
| Breast cancer mortality trends in the US | Take Quiz |
| Breast cancer metastasis | Take Quiz |
| Breast-conserving surgery for breast cancer | Take Quiz |
| Types of mastectomy for breast cancer | Take Quiz |
| Performing biopsy in breast cancer diagnosis | Take Quiz |
| Regional nodal irradiation in breast cancer management | Take Quiz |
| Breast cancer risk among US women | Take Quiz |
| MRI for breast cancer screening | Take Quiz |
| Clinical signs and symptoms of breast cancer | Take Quiz |
| Breast cancer prognoses | Take Quiz |
| Breast tissue density and cancer risk | Take Quiz |
| Modifiable breast cancer risk factors | Take Quiz |
| Personal and family history in breast cancer risk | Take Quiz |
| Breast cancer risk | Take Quiz |
| Breast cancer metabolic tumor volume and endocrine therapy effectiveness | Take Quiz |
| Life-years impact of metastatic breast cancer among US women | Take Quiz |
| Bisphosphonate treatment and breast cancer | Take Quiz |
| USPSTF Recommendations: Breast cancer genetic risk assessment | Take Quiz |
| Prognostic factors for HR-positive HER2-negative breast cancer | Take Quiz |
| Early stage breast cancer and endocrine therapy | Take Quiz |
| Partial vs. whole breast irradiation in cancer management | Take Quiz |
| Early stage breast cancer | Take Quiz |
| Breast cancer: Types of surgery | Take Quiz |
| Circulating tumor cell clusters and metastatic breast cancer outcomes | Take Quiz |
| Breast cancer with leptomeningeal metastasis: Characteristics & outcomes | Take Quiz |
| De novo metastatic breast cancer: Occurrence & outcome by subtype | Take Quiz |
| Metastatic breast cancer: Adapting to changes during treatment | Take Quiz |
| Breast cancer: Tissue diagnosis & imaging studies | Take Quiz |
| Early & advanced breast cancer: Use of imaging in evaluation & follow-up | Take Quiz |
| Breast cancer: Circulating tumor cells | Take Quiz |
| Metastatic breast cancer with ESR1 mutation: Clinical management considerations | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
| ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
| ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
| ASCO/CAP Guidelines: HER2 and FISH testing | Take Quiz |
| Factors related to breast cancer surgery choices | Take Quiz |
| Obesity & postmenopausal breast cancer risk | Take Quiz |
| Breast conservation & neoadjuvant therapy | Take Quiz |
| Oophorectomy & breast cancer | Take Quiz |
| Quiz | |
|---|---|
| B-Cell Lymphoma Relapse | Take Quiz |
| Fast Facts Friday, Aug 13th, 2021 | Take Quiz |
| Fast Facts Friday, Aug 6th, 2021 | Take Quiz |
| Fast Facts Friday, July 30, 2021 | Take Quiz |
| Fast Facts Friday July 23, 2021 | Take Quiz |
| Fast Facts Friday: July 16, 2021 | Take Quiz |
| Fast Facts Friday - 07/09/2021 | Take Quiz |
| Fast Facts Friday July 2, 2021 | Take Quiz |
| Fast Facts Friday June 25, 2021 | Take Quiz |
| Diagnose It: November 28, 2020 | Take Quiz |
| Transformed indolent lymphoma and ASCT | Take Quiz |
| Genes & AML | Take Quiz |
| ALL outcomes in pediatric patients | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 2 | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 1 | Take Quiz |
| Classification of adult ALL | Take Quiz |
| HIV-related lymphomas and AHCT | Take Quiz |
| Adult HL treatment | Take Quiz |
| Diagnosis and assessment of ALL | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 3 | Take Quiz |
| Staging of adult HL | Take Quiz |
| Treatment of adult ALL | Take Quiz |
| Screening & prevention of head & neck cancer | Take Quiz |
| Prognosis of head & neck cancer | Take Quiz |
| Epidemiology & risk factors associated with head & neck cancer | Take Quiz |
| Diagnosis & staging of head & neck cancer | Take Quiz |
| Diagnosis & management of infectious disease syndromes | Take Quiz |
| Evaluation of a neutropenic patient with fever | Take Quiz |
| Myelodysplastic syndrome | Take Quiz |
| Therapeutic approaches to myelodysplastic syndrome | Take Quiz |
B Cell Lymphoma
B Cell Lymphoma
| Quiz | |
|---|---|
| Mantle Cell Lymphoma | Take Quiz |
| CAR T-Cell Therapy in B Cell Lymphoma | Take Quiz |
| Diffuse Large B-Cell Lymphoma | Take Quiz |
AML
AML
| Quiz | |
|---|---|
| Acute Myeloid Leukemia Overview | Take Quiz |
| Acute myeloid leukemia prognosis | Take Quiz |
| Clinical evaluation for acute myeloid leukemia | Take Quiz |
| AML prevalence and onset risk | Take Quiz |
| Managing acute myeloid leukemia | Take Quiz |
| Management of acute myeloid leukemia | Take Quiz |
| Clinical features of acute myeloid leukemia | Take Quiz |
| Clonal hematopoiesis & risk for therapy-related cancer | Take Quiz |
| AML: Androgen maintenance therapy & survival | Take Quiz |
| Leukemia: Survival after cord-blood transplant | Take Quiz |
| Telomere length and delayed bone marrow recovery in pediatric AML | Take Quiz |
| Extramedullary disease & AML survival | Take Quiz |
Hematologic Malignancies
Hematologic Malignancies
| Quiz | |
|---|---|
| Acute Myeloid Leukemia Overview | Take Quiz |
| Antihistamine use for CLL cell death | Take Quiz |
| COVID-19 in patients with CLL | Take Quiz |
| Diagnosing CLL | Take Quiz |
| CLL presentation | Take Quiz |
| CLL management & prognosis | Take Quiz |
| CLL: Risk factors & epidemiology | Take Quiz |
| Diagnosis of CLL | Take Quiz |
Mixed Topics
Mixed Topics
| Quiz | |
|---|---|
| Cardiotoxicity from Cancer Treatment | Take Quiz |
| Late Effects of Anticancer Therapy in Childhood Cancer Survivors | Take Quiz |
Prostate Cancer
Prostate Cancer
| Quiz | |
|---|---|
| Prostate Cancer Considerations | Take Quiz |
| Prostate Cancer Recent Studies | Take Quiz |
Lifestyle
Lifestyle
| Quiz | |
|---|---|
| Diet and Cancer | Take Quiz |
Head & Neck/Thyroid Cancers
Head & Neck/Thyroid Cancers
| Quiz | |
|---|---|
| Diagnosis of Papillary Thyroid Cancer | Take Quiz |
| Thyroid Cancer Presentation and Evaluation | Take Quiz |
| Medullary Thyroid Cancer | Take Quiz |
| Thyroid Cancer Metastasis | Take Quiz |
| Atrial Fibrillation and Other Cardiac Concerns in Thyroid Cancer | Take Quiz |
| Thyroid Cancer Risk Factors | Take Quiz |
| ESMO Thyroid Cancer Treatment Guidelines | Take Quiz |
| Pediatric Thyroid Cancer | Take Quiz |
| Thyroid Cancer Diagnosis | Take Quiz |
| Thyroid carcinoma types | Take Quiz |
| ATA Guidelines: Histopathologic evaluation of thyroidectomy samples in patients with DTC | Take Quiz |
| ATA Guidelines: Secretory products & morphological examination of MTC | Take Quiz |
| ATA Guidelines: Intraoperative voice and parathyroid management & follow-up in patients with DTC | Take Quiz |
| ATA Guidelines: Voice and parathyroid issues in DTC | Take Quiz |
| ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
| Thyroid cancer trends in the United States | Take Quiz |
| DTC detection in obese and non-obese patients | Take Quiz |
| Staging: Papillary & follicular thyroid cancer | Take Quiz |
| Prognostic & risk factors of thyroid cancer | Take Quiz |
| Thyroid nodules & thyroid metastases | Take Quiz |
| Postoperative treatment of WDTC | Take Quiz |
| Recurrent thyroid cancer | Take Quiz |
| Thyroid gland malignancies: DTC, MTC, & ATC | Take Quiz |
| Surgical treatment: Stage III & IV papillary & follicular thyroid cancer | Take Quiz |
| The breast-thyroid cancer link | Take Quiz |
| ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
| Impact of low iodine diet in DTC | Take Quiz |
| ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
| Epidemiology & clinical presentation of parathyroid carcinoma | Take Quiz |
| Diagnosis & treatment of parathyroid carcinoma | Take Quiz |
| Diagnosis & treatment of medullary thyroid cancer | Take Quiz |
| Thyroid cancer outcomes | Take Quiz |
| Clinical presentation & diagnosis of thyroid cancer | Take Quiz |
| ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
| ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
| Surgical treatment of primary stage differentiated thyroid cancer | Take Quiz |
| Treatment of differentiated thyroid cancer | Take Quiz |
| Types of differentiated thyroid cancer | Take Quiz |
COVID-19 Updates
COVID-19 Updates
| Quiz | |
|---|---|
| COVID-19 Brain Fog | Take Quiz |
| Long COVID | Take Quiz |
| COVID-19 Diagnosis | Take Quiz |
| Blood glucose level and COVID-19 hospitalizations | Take Quiz |
| Risk for COVID-19 by type of cancer diagnosis | Take Quiz |
| Providing clinical services during COVID-19 | Take Quiz |
Renal Cell Carcinoma
Renal Cell Carcinoma
| Quiz | |
|---|---|
| Sarcomatoid Renal Cell Carcinoma | Take Quiz |
| Ablation in Renal Cell Carcinoma | Take Quiz |
| Brain Metastasis in Renal Cell Carcinoma | Take Quiz |
| Chromophobe Renal Cell Carcinoma | Take Quiz |
| Renal Cell Carcinoma Comorbidities | Take Quiz |
| Kidney Transplantation in Renal Cell Carcinoma | Take Quiz |
| Renal Cell Carcinoma Treatment Guidelines | Take Quiz |
| Renal Cell Carcinoma Treatment | Take Quiz |
| Clear Cell Papillary Renal Cell Carcinoma | Take Quiz |
| Renal cell carcinoma and bone metastasis | Take Quiz |
| Renal cell carcinoma risk factors | Take Quiz |
| Renal cell carcinoma diagnosis | Take Quiz |
| Renal cell carcinoma in children | Take Quiz |
| Renal cell carcinoma metastasis | Take Quiz |
| Chromophobe renal cell carcinoma | Take Quiz |
| Renal cell carcinoma diagnosis and therapy options | Take Quiz |
| BAP1 protein expression in clear cell RCC | Take Quiz |
| Staging and manifestation of RCC in patients | Take Quiz |
| Prognosis of renal cell carcinoma | Take Quiz |
| Diagnosis of renal cell carcinoma | Take Quiz |
| Features of renal cell carcinoma | Take Quiz |
| Managing clear cell renal cell carcinoma metastases | Take Quiz |
| Renal cell carcinoma recurrence by histological subtype | Take Quiz |
| Managing localized renal cell carcinoma | Take Quiz |
| Renal cell carcinoma prognosis | Take Quiz |
| Renal cell carcinoma risk factors | Take Quiz |
| Imaging of metastatic renal cell carcinoma | Take Quiz |
| ASCO Guidelines: Management of renal cell masses | Take Quiz |
| RCC subtypes: Risk factors, clinical findings, & imaging | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| Staging & surveillance of RCC | Take Quiz |
| Minimally invasive surgery for RCC | Take Quiz |
| Pathophysiology & prognosis of RCC | Take Quiz |
| Unique patient categories in RCC | Take Quiz |
| Management of localized RCC | Take Quiz |
Lung Cancer
Lung Cancer
| Quiz | |
|---|---|
| New Lung Cancer Biomarkers | Take Quiz |
| Lung Metastasis | Take Quiz |
| Lung cancer and nonsmoking risk factors | Take Quiz |
| Lung cancer symptoms and signs | Take Quiz |
| Non–small cell lung cancer subtypes and features | Take Quiz |
| Lung cancer risk in other disease states | Take Quiz |
| Non–small cell lung cancer and treatment evolution | Take Quiz |
| Non–small cell lung cancer and treatment evolution | Take Quiz |
| Small cell lung cancer immunotherapy and outcomes | Take Quiz |
| Lung cancer screening methods | Take Quiz |
| Small cell lung cancer and non–small cell lung cancer diagnosis | Take Quiz |
| Non-small cell lung cancer | Take Quiz |
| Lung cancer risk factors | Take Quiz |
| Non-small cell lung cancer; types and characteristics | Take Quiz |
| Screening of lung cancer in patients | Take Quiz |
| Lung cancer evaluation | Take Quiz |
| Post-treatment morbidity in lung cancer | Take Quiz |
| Surgical management of lung cancer brain metastases | Take Quiz |
| Small cell and non-small cell cancer | Take Quiz |
| Malnutrition and sarcopenia in lung cancer | Take Quiz |
| Lung cancer prognosis factors | Take Quiz |
| COVID-19 and lung cancer | Take Quiz |
| Surgical management of NSCLC | Take Quiz |
| Lung cancer and serum carcinoembryonic antigen | Take Quiz |
| NSCLC staging with lymph node involvement | Take Quiz |
| Low-dose CT screening for lung cancer | Take Quiz |
| Guidelines: Lung cancer screening during COVID-19 | Take Quiz |
| Postoperative radiotherapy for NSCLC with N2 disease | Take Quiz |
| Incidence and prognosis of second lung cancer | Take Quiz |
| Trends in lung cancer mortality | Take Quiz |
| Lung cancer screening for high-risk patients | Take Quiz |
| Stereotactic ablative radiotherapy for NSCLC | Take Quiz |
| Radiomics in lung cancer evaluation | Take Quiz |
| Benefits and risks of lung cancer screening | Take Quiz |
| Clinical methods of lung cancer detection | Take Quiz |
| Lung cancer risk and screening | Take Quiz |
| Principles in treating advanced non-small cell lung cancer | Take Quiz |
| Clinical features of lung cancer | Take Quiz |
| Prognosis in patients with lung cancer | Take Quiz |
| Treating stage III non-small cell lung cancer | Take Quiz |
| Lung function post-radiotherapy for stage III non-small cell lung cancer | Take Quiz |
| Stage IIIA non-small cell lung cancer | Take Quiz |
| Palliative radiotherapy for stage III non-small-cell lung cancer | Take Quiz |
| Treatment effectiveness in stage III non-small cell lung cancer | Take Quiz |
| Inoperable stage III non-small cell lung cancer | Take Quiz |
| Squamous-cell lung cancer biomarkers | Take Quiz |
| NSCLC: Delayed chemo & survival after surgery | Take Quiz |
| Lung cancer: The role of imaging studies & chest CT | Take Quiz |
| Understanding lung cancer | Take Quiz |
| Advanced & previously treated NSCLC: The OAK & POPLAR trials by Bobby Daly, MD, MBA | Take Quiz |
| PD-L1-Positive NSCLC and KEYNOTE-024, by Bobby Daly, MD, MBA | Take Quiz |
| Pathology & clinical presentation of small cell lung cancer | Take Quiz |
| Staging & imaging of small cell lung cancer | Take Quiz |
| Treatment of stage IIIA NSCLCs | Take Quiz |
| RAS mutations in NSCLC by Kevin Wood, MD | Take Quiz |
| Treatment of early-stage NSCLCs | Take Quiz |
| Clinical evaluation of single pulmonary nodules | Take Quiz |
| NSCLC risk and subtypes | Take Quiz |
| Lung cancer pathology | Take Quiz |
Conference Coverage
Conference Coverage
| Quiz | |
|---|---|
| SABCS 2021: Efficacy of selective estrogen receptor degrader in estrogen receptor–positive breast cancer | Take Quiz |
| SABCS 2021: Breast cancer risk factors | Take Quiz |
| SABCS 2021: Breast cancer and liquid biopsy | Take Quiz |
| SABCS 2021: Triple-negative breast cancer and its features | Take Quiz |
| SABCS 2021: Inflammatory breast cancer features | Take Quiz |
| SABCS 2021: Breast cancer mortality and recurrence | Take Quiz |
| ASCO Conference: Survival outcomes in untreated metastatic breast cancer | Take Quiz |
| ASCO Conference: U.S. breast cancer mortality by molecular subtype | Take Quiz |
| ASCO Conference: Chemotherapy for breast cancer | Take Quiz |
| ASCO Conference: Inflammatory cytokines and breast cancer recurrence | Take Quiz |
| ASCO Conference: Managing breast cancer during pregnancy | Take Quiz |
| ASCO Annual Meeting: Patient race and distant metastases in breast cancer | Take Quiz |
| ASH 2020: Effectiveness of ibrutinib and venetoclax in CLL/SLL cases | Take Quiz |
| ASH 2020: Multiple myeloma responses to novel CAR T-cell constructs | Take Quiz |
| ASH 2020: Transplant for myelodysplastic syndrome in elderly patients | Take Quiz |
| ASH 2020: Neurocognitive impairment in pediatric Hodgkin lymphoma survivors | Take Quiz |
| ASH 2020: Allogenic transplant effectiveness in T-cell lymphomas | Take Quiz |
| ASH 2020: Hematologic disease and COVID-19 | Take Quiz |
Hodgkin Lymphoma
Hodgkin Lymphoma
| Quiz | |
|---|---|
| Classic Hodgkin lymphoma and immune checkpoint inhibitor therapy | Take Quiz |
| Classic Hodgkin lymphoma pathology | Take Quiz |
| Classic Hodgkin lymphoma & CNS involvement | Take Quiz |
| Lymphocyte-depleted classic Hodgkin lymphoma | Take Quiz |
| Classical Hodgkin lymphoma features and diagnosis | Take Quiz |
| Diagnosis of classical Hodgkin lymphoma | Take Quiz |
| Features of classical Hodgkin lymphoma | Take Quiz |
| Relapsed/refractory classical Hodgkin lymphoma | Take Quiz |
| Lymphocyte depleted classic Hodgkin lymphoma | Take Quiz |
| Tumor tissue in classical Hodgkin’s lymphoma | Take Quiz |
| Thymus and activation-regulated chemokine in classical Hodgkin lymphoma | Take Quiz |
| Classical Hodgkin lymphoma and patient age | Take Quiz |
| Treatment of advanced-stage classical Hodgkin lymphoma | Take Quiz |
| Treatment of early-stage classical Hodgkin lymphoma | Take Quiz |
| Biopsy for classical Hodgkin lymphoma diagnosis | Take Quiz |
| Bulky disease in classical Hodgkin lymphoma | Take Quiz |
| Subtypes of classical Hodgkin lymphoma | Take Quiz |
| Patient age in classical Hodgkin lymphoma | Take Quiz |
| Managing classical Hodgkin lymphoma | Take Quiz |
| Frontline management of classical Hodgkin lymphoma | Take Quiz |
| Clinical manifestation of lymphocyte-depleted cHL | Take Quiz |
| Classical Hodgkin lymphoma incidence and management | Take Quiz |
| Classical Hodgkin lymphoma subtypes among HL cases | Take Quiz |
| Lymphocyte depleted and mixed-cellularity CHL | Take Quiz |
| Relapsed/refractory classical Hodgkin lymphoma treatments | Take Quiz |
| Standard of care in relapsed/refractory classical Hodgkin lymphoma | Take Quiz |
| Clinical burden of classical Hodgkin lymphoma | Take Quiz |
| Clinical effects of the microenvironment in cHL | Take Quiz |
| Difficulties in clinical management of classic Hodgkin lymphoma | Take Quiz |
| Tumor microenvironment macrophages in classical HL | Take Quiz |
| Treatment effectiveness in classic Hodgkin lymphoma | Take Quiz |
| Bone marrow involvement in cHL | Take Quiz |
| Treating relapsed classical Hodgkin’s lymphoma | Take Quiz |
| HIV infection and classical Hodgkin lymphoma | Take Quiz |
| Treatment of relapsed-refractory classical Hodgkin lymphoma | Take Quiz |
| Cellular-level features in classical Hodgkin’s lymphoma | Take Quiz |
| Laboratory diagnostic testing for classical Hodgkin lymphoma | Take Quiz |
| Stem-cell transplantation effectiveness in refractory classical Hodgkin lymphoma | Take Quiz |
| Prognostic factors in classical Hodgkin lymphoma | Take Quiz |
| Post-treatment outcomes in classical Hodgkin lymphoma | Take Quiz |
| Overview of classical Hodgkin lymphoma | Take Quiz |
| Radiation therapy in treatment of classic Hodgkin lymphoma | Take Quiz |
| Diagnosis of Hodgkin lymphoma | Take Quiz |
| Hodgkin lymphoma risk and prognostic factors | Take Quiz |
Genitourinary Cancer
Genitourinary Cancer
| Quiz | |
|---|---|
| Bladder cancer presentation | Take Quiz |
| Laboratory findings in pheochromocytoma diagnosis | Take Quiz |
| Obesity and cancer incidence | Take Quiz |
| ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
| AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
| RCC subtypes: Risk factors, clinical findings, & imaging | Take Quiz |
| AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| Testicular cancer: Staging & risk stratification | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| AHRQ Review: Management of renal masses & localized renal cancer | Take Quiz |
| Understanding urethral cancer | Take Quiz |
| Staging & surveillance of RCC | Take Quiz |
| Minimally invasive surgery for RCC | Take Quiz |
| Pathophysiology & prognosis of RCC | Take Quiz |
| Risk factors & clinical features of bladder cancer | Take Quiz |
| Unique patient categories in RCC | Take Quiz |
| Management of localized RCC | Take Quiz |
| Serum tumor markers & testicular cancer | Take Quiz |
| Epidemiology & risk factors associated with testicular cancer | Take Quiz |
| AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
| Clinical features and pathology of bladder cancer | Take Quiz |
| Treatment options for stage I & II RCC | Take Quiz |
| Treatment options for RCC | Take Quiz |
| RCC tumor characterization: Laboratory & imaging studies | Take Quiz |
| Genetic risk factors associated with RCC | Take Quiz |
| RCC subtypes | Take Quiz |
| Pathology & natural history of renal cancer | Take Quiz |
| RCC: Links & risk factors | Take Quiz |
| Clinical features & management of RCC | Take Quiz |
| Epidemiology & etiology of RCC | Take Quiz |
| Risk factors and pathology of prostate cancer | Take Quiz |
| Prostate cancer: Disease detection | Take Quiz |
| Diagnosis & prognosis of bladder cancer | Take Quiz |
| Classification of renal cell cancer | Take Quiz |
| Staging of testicular cancer | Take Quiz |
| Risk factors & prostate cancer | Take Quiz |
| ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
| Survival in advanced prostate cancer | Take Quiz |
| Understanding bladder cancer | Take Quiz |
| Treatment of prostate cancer | Take Quiz |
T Cell Lymphomas
T Cell Lymphomas
| Quiz | |
|---|---|
| PTCL subtypes and features | Take Quiz |
| Role of epigenetics in PTCL diagnosis and treatment | Take Quiz |
| Epigenetic alterations in PTCL development | Take Quiz |
| Peripheral T‐cell lymphoma prognosis | Take Quiz |
| Relapsed peripheral T-cell lymphoma | Take Quiz |
| Adult T-cell leukemia-lymphoma | Take Quiz |
| Peripheral T-cell lymphoma risk factors | Take Quiz |
| Prognosis of peripheral T-cell lymphomas | Take Quiz |
| ALK positive/negative anaplastic large cell lymphomas | Take Quiz |
| Extranodal natural killer/T-cell lymphoma prognosis | Take Quiz |
| Diagnosing angioimmunoblastic T cell lymphoma | Take Quiz |
| Breast implant-associated anaplastic large cell lymphoma | Take Quiz |
| Managing angioimmunoblastic T cell lymphoma | Take Quiz |
| Risk and management of peripheral T cell lymphomas | Take Quiz |
| Lab diagnosis of peripheral T-cell lymphoma | Take Quiz |
| Peripheral T-cell lymphoma manifestations | Take Quiz |
| Angioimmunoblastic T-cell lymphoma | Take Quiz |
| Identifying indolent peripheral T-cell lymphomas | Take Quiz |
| Peripheral T-cell lymphoma outcomes | Take Quiz |
| Anaplastic large cell lymphoma | Take Quiz |
| Enteropathy-associated T cell lymphoma | Take Quiz |
| Standard approaches in peripheral T cell lymphoma treatment | Take Quiz |
| Biomarkers for peripheral T cell lymphoma not otherwise specified | Take Quiz |
| Peripheral T-cell lymphoma subtype clinical features | Take Quiz |
| Peripheral T-cell lymphoma treatment outcomes | Take Quiz |
| Physical findings of mycosis fungoides | Take Quiz |
Gynecologic Cancer
Gynecologic Cancer
| Quiz | |
|---|---|
| Guideline-adherent endometrial cancer treatment in the U.S. | Take Quiz |
| Common classifications of ovarian cancer tumors | Take Quiz |
| Ovarian cancer prognosis and outcomes | Take Quiz |
| Oral contraceptive use and ovarian cancer risk | Take Quiz |
| Genetics and ovarian cancer | Take Quiz |
| Diagnosing ovarian cancer | Take Quiz |
| Chemotherapy for ovarian cancer | Take Quiz |
| Ovarian cancer management during COVID-19 | Take Quiz |
| Surgical ovarian cancer management | Take Quiz |
| Ovarian cancer management | Take Quiz |
| Ovarian cancer screening | Take Quiz |
| Tumor markers in ovarian cancer evaluation | Take Quiz |
| Ovarian cancer risk factors | Take Quiz |
| Ovarian cancer signs and symptoms | Take Quiz |
| Managing advanced high-grade serous ovarian cancer | Take Quiz |
| Recent trends in advanced epithelial ovarian cancer management | Take Quiz |
| Transvaginal ultrasound for evaluating ovarian masses | Take Quiz |
| Benign vs malignant ovarian masses | Take Quiz |
| Clinical outcomes in high-grade serous ovarian cancer | Take Quiz |
| Salpingo-oophorectomy and ovarian cancer risk | Take Quiz |
| Tumor factors in epithelial ovarian cancer outcomes | Take Quiz |
| Managing ovarian cancer | Take Quiz |
| Capsule rupture risk with surgery in early-stage ovarian cancer | Take Quiz |
| Breastfeeding and ovarian cancer risk | Take Quiz |
| Ovarian cancer risk from biochemical intakes and exposures | Take Quiz |
| Risk factors for ovarian cancer | Take Quiz |
| Type I and type II tumors in ovarian carcinoma | Take Quiz |
| Clinical aspects of ovarian cancer | Take Quiz |
| Cervical cancer screening in the United States | Take Quiz |
| Cancer risk after cervical intraepithelial neoplasia treatment | Take Quiz |
| Cervicovaginal microbiome and cervical cancer screening | Take Quiz |
| Cervical intraepithelial neoplasia interventions | Take Quiz |
| Cervical cancer development precursors | Take Quiz |
| Diagnostic imaging for cervical cancer evaluation | Take Quiz |
| Ultrasonography findings and ovarian cancer risk | Take Quiz |
| Ovarian cancer treatment | Take Quiz |
| Parity and ovarian cancer risk | Take Quiz |
| Ovarian cancer risk factors | Take Quiz |
| ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
| ASCO Guidelines: Cervical cancer screening | Take Quiz |
| Subtypes of endometrial cancer | Take Quiz |
| Screening & serum biomarkers for EOC | Take Quiz |
| Prevention of EOC with RRSO | Take Quiz |
| Diagnosis, evaluation, and treatment of EOC | Take Quiz |
| Diagnosis & screening of endometrial cancer | Take Quiz |
| Risk factors and screening for endometrial cancer | Take Quiz |
| Prevention and screening of ovarian cancer | Take Quiz |
| EOC pathology | Take Quiz |
| Nodal spread and endometrial cancer | Take Quiz |
Bleeding Disorders
Bleeding Disorders
| Quiz | |
|---|---|
| Hemophilia-associated pain | Take Quiz |
| Guidelines: Bleeding management in von Willebrand disease | Take Quiz |
| Bone mineral density and severe hemophilia A | Take Quiz |
| Immune thrombocytopenia features | Take Quiz |
| Diagnosing von Willebrand disease | Take Quiz |
| Evans syndrome | Take Quiz |
| Hypercoagulable states: Clinical features | Take Quiz |
| Pancytopenia: Patient history & features | Take Quiz |
| Sickle cell trait and HBA1c in African Americans | Take Quiz |
| Hemophilia A and B: Characteristics & diagnosis | Take Quiz |
| Sickle cell trait, rhabdomyolysis, and mortality | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
| Classification of von Willebrand disease | Take Quiz |
| Treatment of von Willebrand disease | Take Quiz |
| Pathophysiology of hemophilia A and B | Take Quiz |
| Clinical manifestations of hemophilia | Take Quiz |
| GVHD: Laboratory & imaging studies | Take Quiz |
GI Oncology
GI Oncology
| Quiz | |
|---|---|
| Colon cancer management decisions | Take Quiz |
| Colorectal cancer risk factors | Take Quiz |
| Managing liver metastases in colon cancer | Take Quiz |
| Colorectal cancer prognosis markers | Take Quiz |
| Adenomas and colorectal cancer | Take Quiz |
| Esophageal adenocarcinoma onset trends | Take Quiz |
| Malignant colorectal polyps: Best practices | Take Quiz |
| Treating severe thrombocytopenia in HCC | Take Quiz |
| Pancreatic cancer screening in high-risk individuals | Take Quiz |
| Glycated hemoglobin levels and risk of pancreatic cancer | Take Quiz |
| NAFLD and hepatocellular carcinoma risk | Take Quiz |
| Hepatocellular carcinoma screening in NAFLD | Take Quiz |
| USPSTF Recommendation: Pancreatic cancer screening | Take Quiz |
| Adenomas and CRC risk | Take Quiz |
| Colorectal cancer trends in the United States | Take Quiz |
| Pancreatic neuroendocrine tumors: Pathogenesis & prognostic factors | Take Quiz |
| Colorectal cancer & endoscopic resection | Take Quiz |
| USPSTF Guidelines: Update on CRC screening | Take Quiz |
| Risk factors & screening for gastric cancers | Take Quiz |
| Diagnostic laparoscopy & management of PDA | Take Quiz |
| Management of PDA & metastatic disease | Take Quiz |
| Treatment of esophageal cancer | Take Quiz |
| Pathology & staging workup of esophageal cancer | Take Quiz |
| Diagnosing PDA: Imaging & aspiration/biopsy | Take Quiz |
| Clinical presentation & diagnosis of esophageal cancer | Take Quiz |
| Epidemiology & etiology of esophageal cancer | Take Quiz |
| Gastric cancer prevention | Take Quiz |
| Rectal cancer: Neoadjuvant therapy vs surgery | Take Quiz |
| Adenoma detection rates in CRC | Take Quiz |
| Preoperative chemotherapy & colorectal cancer | Take Quiz |
| Familial adenomatous polyposis & CRC | Take Quiz |
| Screening of CRC | Take Quiz |
| Colonoscopy: Optimizing adequate bowel cleansing | Take Quiz |
| ASCO Guidelines: Surveillance protocol for survivors of CRC | Take Quiz |
| Epidemiology & risk factors of CRC | Take Quiz |
| Genetic evaluation & management of Lynch syndrome | Take Quiz |
| Laparoscopic resection vs surgery for rectal cancer | Take Quiz |
| Risk factors & prognosis of rectal cancer | Take Quiz |
| Understanding hereditary CRC syndromes: Part 2 | Take Quiz |
| Colorectal cancer screening: Flexible sigmoidoscopy | Take Quiz |
Pediatrics
Pediatrics
| Quiz | |
|---|---|
| Febrile neutropenia in pediatric cancer | Take Quiz |
| Pediatric cancer treatment effects | Take Quiz |
| Sun protection behavior among pediatric hematopoietic stem cell transplants patients | Take Quiz |
| Pediatric cancer and risk of CVD | Take Quiz |
| Von Hippel-Lindau disease | Take Quiz |
Gastrointestinal Cancer
Gastrointestinal Cancer
| Quiz | |
|---|---|
| Aspirin and colorectal cancer risk | Take Quiz |
Transplant
Transplant
| Quiz | |
|---|---|
| Managing chronic graft-versus-host disease | Take Quiz |
Photo Quizzes
Photo Quizzes
| Quiz | |
|---|---|
| Diagnose It: April 10, 2021 | Take Quiz |
| Diagnose It: March 27, 2021 | Take Quiz |
| Diagnose It: March 13, 2021 | Take Quiz |
| Diagnose It: February 27, 2021 | Take Quiz |
| Diagnose It: February 6, 2021 | Take Quiz |
| Diagnose It: December 11, 2020 | Take Quiz |
| Diagnose It: November 13, 2020 | Take Quiz |
| Diagnose It: October 31, 2020 | Take Quiz |
| Diagnose It: October 17, 2020 | Take Quiz |
| Diagnose It: September 26, 2020 | Take Quiz |
| Diagnose It: September 5, 2020 | Take Quiz |
| Diagnose It: August 22, 2020 | Take Quiz |
| Diagnose It: August 8, 2020 | Take Quiz |
| Diagnose It: July 25, 2020 | Take Quiz |
| Diagnose It | Take Quiz |
Melanoma
Melanoma
| Quiz | |
|---|---|
| Autoimmune disease in melanoma | Take Quiz |
| Systemic sclerosis and cancer risk | Take Quiz |
| Artificial UV radiation and second melanoma | Take Quiz |
| Etiology & presentation of squamous cell carcinoma | Take Quiz |
| Uveal choroidal melanoma | Take Quiz |
| Management of metastatic melanoma | Take Quiz |
| Adjuvant treatment of melanoma | Take Quiz |
| Melanoma early diagnosis and staging | Take Quiz |
| Melanoma risk factors | Take Quiz |
| Melanoma: Epidemiology & etiology | Take Quiz |
| Clinical features of melanoma | Take Quiz |
Multiple Myeloma
Multiple Myeloma
| Quiz | |
|---|---|
| Clinical evaluation of multiple myeloma | Take Quiz |
| Treatment burden in multiple myeloma | Take Quiz |
| Multiple myeloma treatment access and survival in the US | Take Quiz |
| Managing successive relapses in multiple myeloma | Take Quiz |
| Managing first relapse in multiple myeloma | Take Quiz |
| Treating newly diagnosed multiple myeloma | Take Quiz |
| Statin use and survival in multiple myeloma | Take Quiz |
| Mortality and survival in active multiple myeloma | Take Quiz |
| Minimal residual disease inside and outside bone marrow | Take Quiz |
| Clinical manifestations in multiple myeloma | Take Quiz |
| Imaging for detection of minimal residual disease in multiple myeloma | Take Quiz |
| Gut activity and microbiome in multiple myeloma | Take Quiz |
| Managing relapsed or refractory multiple myeloma | Take Quiz |
| Vaccine effectiveness for pneumonia prevention in multiple myeloma | Take Quiz |
| Minimal residual disease in multiple myeloma evaluation | Take Quiz |
| Patient race and multiple myeloma risk | Take Quiz |
| Multiple myeloma treatment | Take Quiz |
| Progression and outcomes in multiple myeloma | Take Quiz |
| Multiple myeloma-associated kidney disease | Take Quiz |
| ASCO/CCO Guideline: Assessing multiple myeloma relapse | Take Quiz |
| Whole-body imaging in multiple myeloma | Take Quiz |
| Alcohol consumption and multiple myeloma | Take Quiz |
| Prognosis in multiple myeloma | Take Quiz |
| Bone and multiple myeloma | Take Quiz |
| Complications of multiple myeloma | Take Quiz |
| Clinical progression from MGUS to multiple myeloma | Take Quiz |
| Diagnostic criteria for multiple myeloma | Take Quiz |
| Pathogenesis of multiple myeloma | Take Quiz |
| Multiple myeloma: Epidemiology & features | Take Quiz |
| Myeloma survival: Post-transplant response and minimal residual disease | Take Quiz |
| Multiple myeloma outcomes: Lower- & higher-volume facilities | Take Quiz |
| Multiple myeloma: MRD and survival | Take Quiz |
| Smoldering multiple myeloma in the United States | Take Quiz |
| Prognosis of multiple myeloma | Take Quiz |
| Plasma cell neoplasms: The basics | Take Quiz |
| Treatment of multiple myeloma | Take Quiz |
| Diagnosis and staging of multiple myeloma | Take Quiz |
CLL
CLL
| Quiz | |
|---|---|
| CLL incidence by race and location | Take Quiz |
| Antihistamine use for CLL cell death | Take Quiz |
| COVID-19 in patients with CLL | Take Quiz |
| Diagnosing CLL | Take Quiz |
| CLL presentation | Take Quiz |
| CLL etiology and epidemiology | Take Quiz |
| CLL and minimal residual disease status | Take Quiz |
| CLL, genetic aberrations, & the elderly | Take Quiz |
| Molecular prognostic indicators in CLL | Take Quiz |
| CLL management & prognosis | Take Quiz |
| Diagnosis, classification, & prognostic factors of CLL | Take Quiz |
| CLL: Risk factors & prognostic factors | Take Quiz |
| Staging CLL | Take Quiz |
| Treatment of CLL | Take Quiz |
| Understanding CLL | Take Quiz |
| CLL: Risk factors & epidemiology | Take Quiz |
| Understanding familial CLL | Take Quiz |
| Clinical manifestations of CLL | Take Quiz |
| Diagnosis of CLL | Take Quiz |
Oncology
Oncology
| Quiz | |
|---|---|
| CLL incidence by race and location | Take Quiz |
| COVID-19 in patients with CLL | Take Quiz |
| Diagnosing CLL | Take Quiz |
| CLL presentation | Take Quiz |
| ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
| ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
| NSCLC: Delayed chemo & survival after surgery | Take Quiz |
| ASCO Guidelines: Cancer treatment & cardiac dysfunction risk | Take Quiz |
| PD-based cancer immunotherapy | Take Quiz |
| Lung cancer: The role of imaging studies & chest CT | Take Quiz |
| USPSTF Guidelines: Update on CRC screening | Take Quiz |
| ASCO Guidelines: Management of renal cell masses | Take Quiz |
| ASCO Guidelines: Integrating palliative care | Take Quiz |
| ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
| ASCO Guidelines: Cervical cancer screening | Take Quiz |
| AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA-SUO Guidelines: Diagnosis of non-muscle invasive bladder cancer | Take Quiz |
| CLL management & prognosis | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| CLL: Risk factors & prognostic factors | Take Quiz |
| Treatment of CLL | Take Quiz |
| CLL: Risk factors & epidemiology | Take Quiz |
| Understanding familial CLL | Take Quiz |
| Diagnosis of CLL | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
| ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
| ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
| AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
| ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
| ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
| ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
| ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
| Bowel preparation before colonoscopy | Take Quiz |
| Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
| Colonoscopy surveillance after screening & polypectomy | Take Quiz |
| Endoscopy in the staging & management of CRC | Take Quiz |
| Risk factors & prostate cancer | Take Quiz |
| ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
CML
CML
| Quiz | |
|---|---|
| Diagnostic findings in patients with CML | Take Quiz |
| Management approaches in chronic myeloid leukemia | Take Quiz |
| Initial clinical evaluation in CML diagnosis | Take Quiz |
| Treating chronic myeloid leukemia | Take Quiz |
| Laboratory testing in chronic myeloid leukemia diagnosis | Take Quiz |
| Symptoms of early chronic myeloid leukemia | Take Quiz |
| CML: TKI adherence | Take Quiz |
Pediatric Neuroblastoma
Pediatric Neuroblastoma
| Quiz | |
|---|---|
| Managing pediatric neuroblastoma | Take Quiz |
| Understanding pediatric neuroblastoma | Take Quiz |
Transfusion Medicine
Transfusion Medicine
| Quiz | |
|---|---|
| Delayed hemolytic transfusion reactions | Take Quiz |
| Acute hemolytic transfusion reactions | Take Quiz |
| Platelet transfusion for GI bleeding in patients on antiplatelet agents | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| Transfusion: Age of blood & mortality | Take Quiz |
Sickle Cell Disease
Sickle Cell Disease
| Quiz | |
|---|---|
| Pathophysiology of sickle cell disease complications | Take Quiz |
| Hyponatremia and acute painful episodes in sickle cell disease | Take Quiz |
| Transfusion therapy for sickle cell disease | Take Quiz |
| Features of sickle cell disease in adults | Take Quiz |
| Acute chest syndrome in sickle cell disease | Take Quiz |
| Chronic organ damage in sickle cell disease | Take Quiz |
| Bleeding in sickle cell disease, Part 2 | Take Quiz |
| Bleeding in sickle cell disease, Part 1 | Take Quiz |
| ASH 2020 guidelines for sickle cell disease: Transfusion support, Part 2 | Take Quiz |
| ASH 2020 Guidelines for sickle cell disease: Transfusion support, Part 1 | Take Quiz |
| Guidelines: Cardiopulmonary and kidney disease in patients with sickle cell disease, Part 2 | Take Quiz |
| Guidelines: Cardiopulmonary and kidney disease in patients with sickle cell disease, Part 1 | Take Quiz |
| Common presentations and complications of sickle cell disease | Take Quiz |
| Overview of sickle cell disease | Take Quiz |
Anemia
Anemia
| Quiz | |
|---|---|
| Clinical features of warm autoimmune hemolytic anemia | Take Quiz |
| Warm autoimmune hemolytic anemia diagnosis | Take Quiz |
| Alpha thalassemia: Management | Take Quiz |
| Types of alpha thalassemia | Take Quiz |
| Alpha thalassemia: Physical findings & diagnosis | Take Quiz |
| Drug-induced hemolysis: Pathophysiology, diagnosis, & treatment | Take Quiz |
| Prognosis & management of megaloblastic anemia | Take Quiz |
| Acute complications of sickle cell disease | Take Quiz |
| Chronic complications of sickle cell disease | Take Quiz |
| Anemia in adults | Take Quiz |
| Hydroxyurea & transfusion therapy in sickle cell disease | Take Quiz |
| Anemia in children | Take Quiz |
| Diagnosis of anemia | Take Quiz |
| Mechanisms of anemia | Take Quiz |
| Drug-induced hemolysis: Clinical features | Take Quiz |
| Diagnosis of megaloblastic anemia | Take Quiz |
Immunotherapy
Immunotherapy
| Quiz | |
|---|---|
| Neuromuscular effects of immunotherapy | Take Quiz |
| Cancer preventive & cancer treatment vaccines | Take Quiz |
| Gene-expression profiling of tumors for immunotherapy | Take Quiz |
| Non-specific cancer immunotherapies & adjuvants | Take Quiz |
| Cancer cells & the immune system | Take Quiz |
| Cancer treatment: Monoclonal antibodies | Take Quiz |
| Forms of immunotherapy | Take Quiz |
| Breast cancer: Emerging immunotherapy options | Take Quiz |
| Immunotherapy & non-small cell lung cancer | Take Quiz |
| Immune checkpoints & their inhibitors | Take Quiz |
| Immune checkpoint inhibitors & tumors with mismatch repair deficiency | Take Quiz |
| PD-based cancer immunotherapy | Take Quiz |
| The role of TGF-beta in human cancer | Take Quiz |
| Immune checkpoint blockade: Tumor interferon signaling | Take Quiz |
| Efficacy of adoptive T-cell therapy | Take Quiz |
| Targeting the necrosome for cancer therapy | Take Quiz |
| Mechanisms involved in the tumor microenvironment | Take Quiz |
| B-cell receptor CD4+ T cells in cancer immunotherapy | Take Quiz |
| Improving T-cell potency via the CAR spacer | Take Quiz |
| ROR gamma agonists & antitumor immunity | Take Quiz |
| Role of B cell regulation in carcinogenesis | Take Quiz |
| Cancer therapies: Vaccine adjuvants, Part 2 | Take Quiz |
| Cancer therapies: Vaccine adjuvants, Part 1 | Take Quiz |
| Validation of biomarkers to predict cancer immunotherapy response | Take Quiz |
| Immune checkpoint modulators & immune cell therapy | Take Quiz |
| Function of Hippo pathway kinases in cancer | Take Quiz |
| Cancer immunotherapy: Immune checkpoint blockers | Take Quiz |
| Cancer immunotherapy target: Wnt/β-catenin signaling in dendritic cells | Take Quiz |
| Understanding oncolytic viruses | Take Quiz |
| Cancer immunotherapy: Producer T cells – Part 2 | Take Quiz |
| Cancer immunotherapy: Producer T cells – Part 1 | Take Quiz |
| Cancer immunotherapy: Oncolytic viruses | Take Quiz |
| Immune checkpoint blockade in cancer therapy | Take Quiz |
| Cancer immunotherapy: Targeting microRNAs | Take Quiz |
| Cancer immunotherapy: Role of Tcon & Treg | Take Quiz |
| IL-24 in immunotherapy | Take Quiz |
| Key omics modalities for precision oncology | Take Quiz |
| CAR T cell therapy in cancer treatment | Take Quiz |
| Categories of tumor antigens | Take Quiz |
| Checkpoint blockade therapy: Immune monitoring assays | Take Quiz |
| Principles of cancer immunotherapy | Take Quiz |
| PD-1/PD-L1 immune checkpoint blockade therapy | Take Quiz |
| Oncolytic viruses as immunotherapy | Take Quiz |
| Approaches to cancer immunotherapy | Take Quiz |
| Cancer immunotherapy mechanisms, advantages, & disadvantages | Take Quiz |
| Immunotherapy in MIS CRC | Take Quiz |
| Cancer immunotherapy: CAR design | Take Quiz |
| Precision immunotherapy | Take Quiz |
| Molecular mechanisms of immune avoidance | Take Quiz |
| Immunotherapy for brain tumors | Take Quiz |
| Adenosine in the tumor microenvironment | Take Quiz |
| The role of TILs and MILs in cancer therapy | Take Quiz |
| Leveraging the antigenic identity of tumors | Take Quiz |
| Advances in cancer immunotherapy | Take Quiz |
| Novel technologies for cancer immunotherapy | Take Quiz |
| Understanding cancer immunology & immunotherapy | Take Quiz |
| Personalized cancer immunotherapy: Novel immune monitoring | Take Quiz |
| Understanding cancer immunotherapy | Take Quiz |
ASH 2019
ASH 2019
| Quiz | |
|---|---|
| Risk of venous thromboembolism post-surgery | Take Quiz |
| Patient age and chronic lymphocytic leukemia outcomes | Take Quiz |
| Comorbidities and mortality in elderly patients with chronic lymphocytic leukemia | Take Quiz |
| Thrombosis prevention and bleeding risk in anticoagulant combination therapy | Take Quiz |
| Intracranial hemorrhage and immune thrombocytopenia inpatients | Take Quiz |
| Clinical Guideline: Preventing VTE in surgical patients | Take Quiz |
Metastatic Breast Cancer
Metastatic Breast Cancer
| Quiz | |
|---|---|
| Life-years impact of metastatic breast cancer among US women | Take Quiz |
| De novo metastatic breast cancer: Occurrence & outcome by subtype | Take Quiz |
| Metastatic breast cancer: Adapting to changes during treatment | Take Quiz |
| Metastatic breast cancer with ESR1 mutation: Clinical management considerations | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
Lymphoma & Plasma Cell Disorders
Lymphoma & Plasma Cell Disorders
| Quiz | |
|---|---|
| Overview of BIA-ALCL | Take Quiz |
| Treatment of adult HL | Take Quiz |
| Diagnosis & pathogenesis of primary CNS lymphoma | Take Quiz |
| Indolent & aggressive NHL | Take Quiz |
| Cellular classification & treatment of NHL | Take Quiz |
| Understanding NHL | Take Quiz |
| Prognosis of primary CNS lymphoma | Take Quiz |
Gastroenterology
Gastroenterology
| Quiz | |
|---|---|
| Post-surgical survival factors in pancreatic cancer | Take Quiz |
| Diet and hepatocellular carcinoma risk | Take Quiz |
| Precancerous colorectal neoplasms and race | Take Quiz |
| HCC: Prognosis, diagnostic imaging & liver biopsy | Take Quiz |
| Neuroendocrine tumors: Diagnosis | Take Quiz |
| Pancreatic neuroendocrine tumors: Pathogenesis & prognostic factors | Take Quiz |
| Colorectal cancer & endoscopic resection | Take Quiz |
| USPSTF Guidelines: Update on CRC screening | Take Quiz |
| Pathophysiology & prognosis of PDA | Take Quiz |
| Staging, radiographic, & laboratory evaluation of PDA | Take Quiz |
| Bowel preparation before colonoscopy | Take Quiz |
| Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
| Colonoscopy surveillance after screening & polypectomy | Take Quiz |
| Endoscopy in the staging & management of CRC | Take Quiz |
Thrombosis
Thrombosis
| Quiz | |
|---|---|
| Guideline Update: Preventing venous thromboembolism in medical inpatients | Take Quiz |
| Characteristics of essential thrombocythemia | Take Quiz |
| Pathogenesis of immune thrombocytopenia | Take Quiz |
| Hypercoagulable states: Clinical features | Take Quiz |
| ASH Guidelines: Subsequent management of ITP | Take Quiz |
| ASH Guidelines: Initial management of immune thrombocytopenia | Take Quiz |
| ASH Guidelines: Typical features & diagnosis of immune thrombocytopenia | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 1 | Take Quiz |
Sarcoma & GIST
Sarcoma & GIST
| Quiz | |
|---|---|
| Managing alveolar soft-part sarcoma | Take Quiz |
| Sarcoma: Importance of histology | Take Quiz |
| Sarcoma imaging: STS or benign processes? | Take Quiz |
| High-risk sarcomas & chemoradiation | Take Quiz |
| Sarcoma: Radiotherapy benefits | Take Quiz |
| Sarcoma: Radiation and surgical options | Take Quiz |
| Stages of sarcoma | Take Quiz |
| Diagnosing sarcoma | Take Quiz |
| Sarcoma: Disease overview | Take Quiz |
HIV
HIV
| Quiz | |
|---|---|
| HIV: Diarrheal alimentary tract disease, Part 1 | Take Quiz |
CNS/Brain Cancer
CNS/Brain Cancer
| Quiz | |
|---|---|
| Glioblastoma | Take Quiz |
Indolent Lymphoma
Indolent Lymphoma
| Quiz | |
|---|---|
| Mycosis fungoides: Early stages & treatment | Take Quiz |
| Nodal marginal zone lymphoma: Epidemiology & clinical presentation | Take Quiz |
| Splenic marginal zone lymphoma: Features, diagnosis, & management | Take Quiz |
| Indolent B-cell lymphoma: Autologous & allogeneic stem cell transplantation | Take Quiz |
| Waldenström’s macroglobulinemia & stem cell transplantation | Take Quiz |
| Characteristics across indolent NHL subtypes | Take Quiz |
| Mycosis fungoides: Clinical presentation, prognosis, & survival | Take Quiz |
| A subset of indolent lymphomas: Features & outcomes | Take Quiz |
| Mass cytometry study of follicular lymphoma tumors reveals cellular characteristics | Take Quiz |
| Cutaneous B-cell lymphoma: Epidemiology & diagnosis | Take Quiz |
| Marginal zone lymphoma & primary cutaneous anaplastic large cell lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Marginal zone lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Lymphoplasmacytic lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Follicular lymphoma | Take Quiz |
| Waldenström macroglobulinemia: Symptoms & criteria for treatment | Take Quiz |
Clinical Guidelines
Clinical Guidelines
| Quiz | |
|---|---|
| ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
| ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
| ASCO Guidelines: Cancer treatment & cardiac dysfunction risk | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| ASCO Guidelines: Management of renal cell masses | Take Quiz |
| ATA Guidelines: Intraoperative voice and parathyroid management & follow-up in patients with DTC | Take Quiz |
| ATA Guidelines: Voice and parathyroid issues in DTC | Take Quiz |
| ASCO Guidelines: Integrating palliative care | Take Quiz |
| ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
| ASCO Guidelines: Cervical cancer screening | Take Quiz |
| ASBMT Guidelines: Autologous progenitor cell transplant | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
| ASBMT Guidelines: Autologous & allogeneic HCT considerations in special populations & comorbidities | Take Quiz |
| AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
| ASBMT Guidelines: Allogeneic progenitor cell transplant | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA-SUO Guidelines: Diagnosis of non-muscle invasive bladder cancer | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
| Acute complications of sickle cell disease | Take Quiz |
| Chronic complications of sickle cell disease | Take Quiz |
| Hydroxyurea & transfusion therapy in sickle cell disease | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
| ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
| ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
| AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
| ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
| ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
| ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
| ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
| Bowel preparation before colonoscopy | Take Quiz |
| Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
| Colonoscopy surveillance after screening & polypectomy | Take Quiz |
| Endoscopy in the staging & management of CRC | Take Quiz |
| Risk factors & prostate cancer | Take Quiz |
| ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
Nonmelanoma Skin Cancer
Nonmelanoma Skin Cancer
| Quiz | |
|---|---|
| First FDA-approved Merkel cell carcinoma treatment | Take Quiz |
Patient & Survivor Care
Patient & Survivor Care
| Quiz | |
|---|---|
| HCT & non-HCT cancer survivors: Morbidity & mortality | Take Quiz |
| ASCO Guidelines: Integrating palliative care | Take Quiz |
| Cancer survivors: Medication use for anxiety & depression | Take Quiz |
Myelodysplastic Syndrome
Myelodysplastic Syndrome
| Quiz | |
|---|---|
| Clonal hematopoiesis & risk for therapy-related cancer | Take Quiz |
| Myelodysplastic syndrome: Genetic mutations & outcomes | Take Quiz |
| Chronic myelomonocytic leukemia: Survival after transplant | Take Quiz |
Cellular Therapy
Cellular Therapy
| Quiz | |
|---|---|
| Prognostic value of hematopoietic cell transplant comorbidity index | Take Quiz |
| Myelodysplastic syndrome: Genetic mutations & outcomes | Take Quiz |
| HSC donors & health-related quality of life | Take Quiz |
| HSCT outcomes & vancomycin-resistant enterococcus colonization & bacteremia | Take Quiz |
| Double-hit lymphomas: Outcomes after ASCT | Take Quiz |
ALL
ALL
| Quiz | |
|---|---|
| Guidelines: Diagnostic workup of acute leukemia | Take Quiz |
| NCHS Report: Pediatric cancer rates | Take Quiz |
| Ph-like ALL in adults | Take Quiz |
| Acute leukemia: Epidemiology & pathophysiology | Take Quiz |
| Clinical signs & symptoms of acute leukemia | Take Quiz |
| Initial management & tumor lysis syndrome in acute leukemia | Take Quiz |
Hematology
Hematology
| Quiz | |
|---|---|
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| ASBMT Guidelines: Autologous progenitor cell transplant | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| ASBMT Guidelines: Autologous & allogeneic HCT considerations in special populations & comorbidities | Take Quiz |
| ASBMT Guidelines: Allogeneic progenitor cell transplant | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
Aggressive Lymphomas
Aggressive Lymphomas
| Quiz | |
|---|---|
| Double-hit lymphomas: Outcomes after ASCT | Take Quiz |
| HCV: Increased non-Hodgkin lymphoma risk? | Take Quiz |
| Non-Hodgkin lymphoma risk & HIV-Hepatitis coinfection | Take Quiz |
Case-Based Quizzes
Case-Based Quizzes
| Quiz | |
|---|---|
| Advanced & previously treated NSCLC: The OAK & POPLAR trials by Bobby Daly, MD, MBA | Take Quiz |
| PD-L1-Positive NSCLC and KEYNOTE-024, by Bobby Daly, MD, MBA | Take Quiz |
Mantle Cell Lymphoma
Mantle Cell Lymphoma
| Quiz | |
|---|---|
| MCL: Epidemiology, subtypes, & diagnosis | Take Quiz |
| MCL: Diagnosis, treatment, & prognosis | Take Quiz |
Leukemia, Myelodysplasia, Transplantation
Leukemia, Myelodysplasia, Transplantation
| Quiz | |
|---|---|
| Testing & mutational analysis in chronic myeloid leukemia | Take Quiz |